145 5 General Discussion 15. Snapp H, Vogt K, Agterberg MJH. Bilateral bone conduction stimulation provides reliable binaural cues for localization. Hear Res. 2020 Mar 15;388:107881 16. Gawliczek T, Wimmer W, Munzinger F, Caversaccio M, Kompis M. Speech Understanding and Sound Localization with a New Nonimplantable Wearing Option for Baha. Biomed Res Int. 2018 Sep 25;2018:5264124 17. Shiraishi K. Sound Localization and Lateralization by Bilateral Bone Conduction Devices, Middle Ear Implants, and Cartilage Conduction Hearing Aids. Audiol Res. 2021 Sep 30;11(4):508-523 18. Banga R, Child A, Reid A, McDermott AL Subjective benefit following the addition of a second BP100 softband processor for children with bilateral conductive hearing loss. Chapter 6 pp 129-141 PhD Thesis Banga, 2013 Nijmegen 19. Osborne MS, Hoskison E, Child-Hymas A, Gill J, McDermott AL. Five year clinical outcomes and evaluation following implantation of the Oticon™ wide bone anchored hearing system in 47 children. Int J Pediatr Otorhinolaryngol. 2020 Oct;137:110244 20. Osborne MS, Child-Hymas A, Holmberg M, Thomsen P, Johansson ML, McDermott AL. Clinical Evaluation of a Novel Laser-Ablated Titanium Implant System for Bone Anchored Hearing Systems in a Pediatric Population and the Relationship of Resonance Frequency Analysis With Implant Survival. Otol Neurotol. 2022 Feb 1;43(2):219-226. 21. Alexander NL, Silva RC, Barton G, Liu YC. Acquisition limitations of bone conduction hearing devices in children with unilateral microtia and atresia. Int J Pediatr Otorhinolaryngol. 2020 Jul;134:110040 22. Fussey JM, Harterink E, Gill J, Child-Hymas A, McDermott AL. Clinical outcomes following Cochlear™ BIA300 bone anchored hearing aid implantation in children. Int J Pediatr Otorhinolaryngol. 2018 ;111:89-92 23. Crowder HR, Bestourous DE, Reilly BK. Adverse events associated with Bonebridge and Osia bone conduction implant devices. Am J Otolaryngol. 2021 Jul-Aug;42(4):102968 24. Florentine MM, Virbalas J, Chan DK. Early surgical and audiologic outcomes of active, transcutaneous, osseointegrated bone-conduction hearing device (Osia 2® system) placement. Int J Pediatr Otorhinolaryngol. 2022 May;156:111114 25. You P, Choi A, Drob J, Hunsaker SM, Liu YC, Silva R. Early Outcomes of a New Active Transcutaneous Bone Conduction Implant in Pediatric Patients. Otol Neurotol. 2022 Feb 1;43(2):212-218 26. Ernst A, Todt I, Wagner J. Safety and effectiveness of the Vibrant Soundbridge in treating conductive and mixed hearing loss: A systematic review. Laryngoscope. 2016 Jun;126(6):1451-7 27. Cremers CW, O’Connor AF, Helms J, Roberson J, Clarós P, Frenzel H, Profant M, Schmerber S, Streitberger C, Baumgartner WD, Orfila D, Pringle M, Cenjor C, Giarbini N, Jiang D, Snik AF. International consensus on Vibrant Soundbridge® implantation in children and adolescents. Int J Pediatr Otorhinolaryngol. 2010 Nov;74(11):1267-9 28. Hempel JM, Sprinzl G, Riechelmann H, Streitberger C, Giarbini N, Stark T, Zorowka P, Koci V, Magele A, Strenger T, Müller J, Wollenberg B, Frenzel H. A Transcutaneous Active Middle Ear
RkJQdWJsaXNoZXIy MTk4NDMw